Our PM has announced that we need to have new antibiotics (Report, two July), since resistance to present stock poses a significant international overall health risk. Properly carried out, though this is not news considering that the healthcare profession has been warning of the coming crisis for fairly a time. Nevertheless, he appears unaware of the irony of his place. The pharmaceutical industry has been slow to pursue research, because it is difficult and pricey and the fiscal returns on any new improvement might fail to satisfy their pockets. Antibiotics are brief-phrase therapies, unlike drugs designed for chronic illnesses, and new antibiotics will be utilized sparingly for essential problems or publish-operative care, since broader availability may possibly produce the dilemma it is attempting to fix – that of drug resistance. The lesson for Cameron could be that in an area the place society wants sustained investment, marketised medication is failing. But he prospects a government hell-bent on marketising massive swaths of socially presented companies, including healthcare. The proof suggests that markets can’t always supply what society needs, and with antibiotics the nightmare is currently starting.
Tony Tucker
Frodsham, Cheshire
Resisting antibiotics | @guardianletters
Hiç yorum yok:
Yorum Gönder